Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

03/30/08 Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: Phase 1 trial in adults with malignant glioma.        

03/30/08 Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.        

03/30/08 The harm-benefit tradeoff in "bad deal" trials.        

03/27/08 Your $1 in a Million and Our Hero of Hope        

03/22/08 Dan's Fund Created at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute to support Brain Cancer Research        

03/22/08 Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer        

03/18/08 Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials        

03/18/08 Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.        

03/18/08 Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.        

03/18/08 Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.        

03/18/08 Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.        

03/18/08 Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.        

03/18/08 Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.        

03/18/08 Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status.        

03/18/08 Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.        

03/18/08 A fatal outcome in a patient with glioblastoma multiforme after receiving high-dose methotrexate.        

03/18/08 Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).        

03/18/08 Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas        

03/18/08 Signaling System May Halt Brain Cancer        

---

Displaying Stories 3601 to 3620 of 7673
Previous 20           Next 20